Development of a novel B-cell lymphoma 6 (BCL6) PROTAC to provide insight into small molecule targeting of BCL6

W McCoull, T Cheung, E Anderson, P Barton… - ACS Chemical …, 2018 - ACS Publications
B-cell lymphoma 6 (BCL6) inhibition is a promising mechanism for treating hematological
cancers but high quality chemical probes are necessary to evaluate its therapeutic potential …
被引用次数：136 相关文章

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6

W McCoull, T Cheung, E Anderson… - ACS chemical …, 2018 - pubmed.ncbi.nlm.nih.gov
B-cell lymphoma 6 (BCL6) inhibition is a promising mechanism for treating hematological
cancers but high quality chemical probes are necessary to evaluate its therapeutic potential …

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6.

W McCoull, T Cheung, E Anderson, P Barton… - ACS Chemical …, 2018 - europepmc.org
B-cell lymphoma 6 (BCL6) inhibition is a promising mechanism for treating hematological
cancers but high quality chemical probes are necessary to evaluate its therapeutic potential …

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC to Provide Insight into Small Molecule Targeting of BCL6

W McCoull, T Cheung, E Anderson, P Barton… - ACS Chemical …, 2018 - eprints.ncl.ac.uk
Abstract B-cell lymphoma 6 (BCL6) inhibition is a promising mechanism for treating
hematological cancers but high quality chemical probes are necessary to evaluate its …

[引用][C] Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6

W McCoull, T Cheung, E Anderson, P Barton… - ACS Chemical …, 2018 - cir.nii.ac.jp
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small
Molecule Targeting of BCL6 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6

W McCoull, T Cheung, E Anderson, P Barton… - ACS Chemical …, 2018 - osti.gov
B-cell lymphoma 6 (BCL6) inhibition is a promising mechanism for treating hematological
cancers but high quality chemical probes are necessary to evaluate its therapeutic potential …